Adelaide Research & Scholarship: Search

Search

Results 1-10 of 46 (Search time: 0.002 seconds).

previous
1
2
3
4
...
5
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2005	Platelet nitrate responsiveness in fasting and postprandial type 2 diabetes	Anderson, R.; Ellis, G.; Evans, L.; Morris, K.; Chirkov, Y.; Horowitz, J.; Jackson, S.; Rees, A.; Lewis, M.; Frenneaux, M.
	1996	Gastric emptying in "early" non-insulin dependent diabetes mellitus	Jones, K.; Horowitz, M.; Carney, B.; Wishart, J.; Guha, S.; Green, L.
	2018	High baseline levels of tumor necrosis factor receptor 1 are associated with progression of kidney disease in Indigenous Australians with diabetes: the eGFR follow-up study	Barr, E.L.; Barzi, F.; Hughes, J.T.; Jerums, G.; Hoy, W.E.; O'Dea, K.; Jones, G.R.; Lawton, P.D.; Brown, A.D.; Thomas, M.; Ekinci, E.I.; Sinha, A.; Cass, A.; MacIsaac, R.J.; Maple-Brown, L.J.
	2020	The association between age of onset of type 2 diabetes with the long-term risk of end-stage kidney disease: a National Registry study	Morton, J.I.; Liew, D.; McDonald, S.P.; Shaw, J.E.; Magliano, D.J.
	2014	A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial	Tay, J.; Luscombe-Marsh, N.; Thompson, C.; Noakes, M.; Buckley, J.; Wittert, G.; Yancy, W.; Brinkworth, G.
	2019	Gastric emptying in patients with well-controlled type 2 diabetes compared with young and older control subjects without diabetes	Watson, L.E.; Xie, C.; Wang, X.; Li, Z.; Phillips, L.K.; Sun, Z.; Jones, K.L.; Horowitz, M.; Rayner, C.K.; Wu, T.
	2020	Dalcetrapib reduces risk of new-onset diabetes in patients with coronary heart disease	Schwartz, G.G.; Leiter, L.A.; Ballantyne, C.M.; Barter, P.J.; Black, D.M.; Kallend, D.; Laghrissi-Thode, F.; Leitersdorf, E.; McMurray, J.J.V.; Nicholls, S.J.; Olsson, A.G.; Preiss, D.; Shah, P.K.; Tardif, J.-C.; Kittelson, J.
	2007	The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes - Mediation by superoxide production resolution with intensive insulin administration	Worthley, M.; Holmes, A.; Willoughby, S.; Kucia, A.; Heresztyn, T.; Stewart, S.; Chirkov, Y.; Zeitz, C.; Horowitz, J.
	2021	Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial	Wittert, G.; Bracken, K.; Robledo, K.P.; Grossmann, M.; Yeap, B.B.; Handelsman, D.J.; Stuckey, B.; Conway, A.; Inder, W.; McLachlan, R.; Allan, C.; Jesudason, D.; Fui, M.N.T.; Hague, W.; Jenkins, A.; Daniel, M.; Gebski, V.; Keech, A.
	2018	A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes	Van Zuydam, N.R.; Ahlqvist, E.; Sandholm, N.; Deshmukh, H.; William Rayner, N.; Abdalla, M.; Ladenvall, C.; Ziemek, D.; Fauman, E.; Robertson, N.R.; McKeigue, P.M.; Valo, E.; Forsblom, C.; Harjutsalo, V.; Perna, A.; Rurali, E.; Loredana Marcovecchio, M.; Igo, R.P.; Salem, R.M.; Perico, N.; et al.